Multiple Sclerosis Clinical Trial
Official title:
Targeted Strength Training to Improve Gait in People With Multiple Sclerosis: a Feasibility Study
Verified date | April 2018 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will pilot a strengthening intervention targeted to muscles found to be important to gait in people with multiple sclerosis (MS). Previous studies that have tried to strengthen leg and trunk muscles in people with MS have failed to improve walking ability consistently. The investigators think that is because strengthening exercises were not targeted to the correct muscle groups. For this study the investigators propose targeting muscle groups that they have found to be strong contributors to walking in a prior study. This is the first study to target these muscles, so the investigators propose doing a small trial to first evaluate the feasibility of the strength program and the outcomes. The investigators will measure strength and walking measures twice before and once after an 8-week strengthening intervention in a single group of 10 people with MS who are able to walk independently. The results of this study will help inform future, larger trials that could change the way strength training is conducted in people with MS.
Status | Completed |
Enrollment | 11 |
Est. completion date | November 8, 2017 |
Est. primary completion date | November 8, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. People with MS, 2. Age 18-65, 3. A confirmed diagnosis of MS, and 4. Are ambulatory for 100m without an assistive device (EDDS 0-5.5), and 5. Have a gait speed measured by time to walk the 25-foot walk test of at least five seconds. Exclusion Criteria: 1. Subjects are not ambulatory, 2. Subjects rely on a wheelchair, 3. Subjects cannot ambulate 100m (EDDS 6 or greater) without use of assistive devices, braces, or orthotics, 4. Walk the T25FW in less than five seconds, 5. Have lower extremity spasticity of 2 or greater on the Modified Ashworth Scale (MAS), 6. Have pain or other conditions that limit ambulation or ability to test muscle strength, 7. Cannot give consent, 8. Cannot follow simple directions, 9. Have had an exacerbation in the past month, 10. Have had changes to their drug therapy in the last month, 11. Have other neurologic diagnoses, or 12. Are currently undergoing physical therapy for strength training. |
Country | Name | City | State |
---|---|---|---|
United States | University of Colorado Denver | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver |
United States,
Mañago MM, Hebert JR, Schenkman M. Psychometric Properties of a Clinical Strength Assessment Protocol in People with Multiple Sclerosis. Int J MS Care. 2017 Sep-Oct;19(5):253-262. doi: 10.7224/1537-2073.2016-078. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Muscle Strength | Muscle strength measured by hand-held dynamometry (HHD) and clinical strength tests | Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up) | |
Primary | Change in Timed 25 Foot Walk (T25FW) | Gait speed over a 25 foot distance | Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up) | |
Secondary | Change in 6-Minute Walk Test | Gait endurance | Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up) | |
Secondary | Change in Dynamic Gait Index | Balance during gait and other functional activities | Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up) | |
Secondary | Change in Multiple Sclerosis Walking Scale-12 | Self-report measure of limitations in walking related activities | Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up) | |
Secondary | Change in Patient Specific Functional Scale | Self reported measure of self-selected limitations in participation | Week 0 (Baseline 1); Week 10 (Follow-Up) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |